Savara Pharmaceuticals
SVRA
#6613
Rank
C$0.72 B
Marketcap
$4.20
Share price
-6.58%
Change (1 day)
-16.18%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -C$0.11 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$77.05 Million a decrease over its 2022 earnings that were of -C$53.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.11 Billion32.28%
2023 -C$77.05 Million43.38%
2022 -C$53.74 Million-11.31%
2021 -C$60.59 Million-13.3%
2020 -C$69.89 Million-36.53%
2019 -C$0.12 Billion13.76%
2018 -C$96.8 Million105.54%
2017 -C$47.1 Million34.11%
2016 -C$35.12 Million-37.43%
2015 -C$56.13 Million38.81%
2014 -C$40.43 Million33.62%
2013 -C$30.26 Million38.49%
2012 -C$21.85 Million24.59%
2011 -C$17.54 Million-36.5%
2010 -C$27.62 Million-3.14%
2009 -C$28.52 Million-23.28%
2008 -C$37.17 Million8.52%
2007 -C$34.25 Million-34.14%
2006 -C$52 Million184.43%
2005 -C$18.29 Million90.75%
2004 -C$9.59 Million190.35%
2003 -C$3.31 Million11.64%
2002 -C$2.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$25.58 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.35 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA